Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)

v3.22.2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Investment at cost basis $ 19,302 $ 14,002
Deferred revenue $ 2,230 $ 2,586
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, authorized (in shares) 5,000,000 5,000,000
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, authorized (in shares) 100,000,000 100,000,000
Common stock, issued (in shares) 65,494,000 65,109,000
Common stock, outstanding (in shares) 65,494,000 65,109,000
Affiliated Entity    
Investment at cost basis $ 12,713 $ 12,713
Deferred revenue $ 0 $ 245